Average Co-Inventor Count = 4.07
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (57 from 4,948 patents)
2. Other (8 from 832,880 patents)
3. Vernalis Research Limited (6 from 43 patents)
4. Roche Palo Alto LLC (1 from 322 patents)
5. Vernal Research Limited (1 from 1 patent)
6. F. Hoffmann-la Roche Ag (168 patents)
66 patents:
1. 12281124 - Heterocyclic compounds as monoacylglycerol lipase inhibitors
2. 11802133 - Heterocyclic compounds as monoacylglycerol lipase inhibitors
3. 11608347 - Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors
4. 11420961 - Heterocyclic compounds
5. 11390610 - Piperazine derivatives as MAGL inhibitors
6. 11352330 - Phenoxymethyl derivatives
7. 10640472 - Phenoxymethyl derivatives
8. 10618897 - Spiroindolinones as DDR1 inhibitors
9. 10435407 - Triaza-spirodecanones as DDR1 inhibitors
10. 10385022 - 3-amino-pyridines as GPBAR1 agonists
11. 10239876 - Triaza-spirodecanones as DDR1 inhibitors
12. 9708340 - Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors
13. 9604977 - Bicyclic thiophenylamide compounds
14. 9562052 - Bicyclicpyridine derivatives
15. 9353102 - Non-annulated thiophenylamides